PortfoliosLab logoPortfoliosLab logo
CRDO vs. ANAB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CRDO vs. ANAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Credo Technology Group Holding Ltd (CRDO) and AnaptysBio, Inc. (ANAB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CRDO achieves a 54.47% return, which is significantly lower than ANAB's 58.91% return.


CRDO

1D
7.43%
1M
17.91%
YTD
54.47%
6M
24.21%
1Y
204.65%
3Y*
138.04%
5Y*
10Y*

ANAB

1D
1.97%
1M
-25.92%
YTD
58.91%
6M
73.08%
1Y
225.06%
3Y*
60.31%
5Y*
26.26%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CRDO vs. ANAB - Yearly Performance Comparison


2026 (YTD)2025202420232022
CRDO
Credo Technology Group Holding Ltd
54.47%114.09%245.20%46.28%14.25%
ANAB
AnaptysBio, Inc.
58.91%266.16%-38.19%-30.88%3.33%

Correlation

The correlation between CRDO and ANAB is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jan 28, 2022

0.20

Fundamentals

Market Cap

CRDO:

$42.83B

ANAB:

$1.47B

EPS

CRDO:

$2.50

ANAB:

-$0.91

PS Ratio

CRDO:

31.50

ANAB:

6.51

PB Ratio

CRDO:

20.75

ANAB:

115.60

Total Revenue (TTM)

CRDO:

$1.34B

ANAB:

$232.39M

Gross Profit (TTM)

CRDO:

$908.35M

ANAB:

$245.59M

EBITDA (TTM)

CRDO:

$463.79M

ANAB:

$52.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CRDO vs. ANAB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRDO
CRDO Risk / Return Rank: 8787
Overall Rank
CRDO Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
CRDO Sortino Ratio Rank: 8686
Sortino Ratio Rank
CRDO Omega Ratio Rank: 8383
Omega Ratio Rank
CRDO Calmar Ratio Rank: 8888
Calmar Ratio Rank
CRDO Martin Ratio Rank: 8787
Martin Ratio Rank

ANAB
ANAB Risk / Return Rank: 9595
Overall Rank
ANAB Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
ANAB Sortino Ratio Rank: 9494
Sortino Ratio Rank
ANAB Omega Ratio Rank: 9393
Omega Ratio Rank
ANAB Calmar Ratio Rank: 9696
Calmar Ratio Rank
ANAB Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRDO vs. ANAB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Credo Technology Group Holding Ltd (CRDO) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CRDOANABDifference
Sharpe ratioReturn per unit of total volatility

-0.87

Sortino ratioReturn per unit of downside risk

-0.94

Omega ratioGain probability vs. loss probability

1.32

1.49

-0.17

Calmar ratioReturn relative to maximum drawdown

3.84

8.05

-4.21

Martin ratioReturn relative to average drawdown

9.27

20.07

-10.79

CRDO vs. ANAB - Sharpe Ratio Comparison

The current CRDO Sharpe Ratio is 2.43, which is comparable to the ANAB Sharpe Ratio of 3.29. The chart below compares the historical Sharpe Ratios of CRDO and ANAB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CRDOANABDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.43

3.29

-0.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

1.20

0.23

+0.96

Drawdowns

CRDO vs. ANAB - Drawdown Comparison

The maximum CRDO drawdown since its inception was -62.04%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for CRDO and ANAB.


Loading charts...

Drawdown Indicators


CRDOANABDifference

Max Drawdown

Largest peak-to-trough decline

-62.04%

-92.08%

+30.04%

Max Drawdown (1Y)

Largest decline over 1 year

-53.59%

-28.15%

-25.44%

Max Drawdown (3Y)

Largest decline over 3 years

-61.05%

-69.32%

+8.27%

Max Drawdown (5Y)

Largest decline over 5 years

-69.32%

Current Drawdown

Current decline from peak

-5.83%

-40.07%

+34.24%

Average Drawdown

Average peak-to-trough decline

-19.46%

-64.71%

+45.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.17%

11.27%

+10.90%

Volatility

CRDO vs. ANAB - Volatility Comparison

Credo Technology Group Holding Ltd (CRDO) has a higher volatility of 28.82% compared to AnaptysBio, Inc. (ANAB) at 12.10%. This indicates that CRDO's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CRDOANABDifference

Volatility (1M)

Calculated over the trailing 1-month period

28.82%

12.10%

+16.72%

Volatility (6M)

Calculated over the trailing 6-month period

64.61%

46.22%

+18.39%

Volatility (1Y)

Calculated over the trailing 1-year period

85.09%

68.91%

+16.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.41%

65.30%

+16.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.41%

75.47%

+5.94%

Dividends

CRDO vs. ANAB - Dividend Comparison

Neither CRDO nor ANAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CRDO vs. ANAB - Financials Comparison

This section allows you to compare key financial metrics between Credo Technology Group Holding Ltd and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
437.00M
25.56M
(CRDO) Total Revenue
(ANAB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CRDO and ANAB have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CRDO has higher volatility (28.82%) compared to ANAB (12.10%). In terms of maximum drawdown, CRDO dropped -62.04% vs ANAB's -92.08%.

ANAB currently has the higher Sharpe Ratio (3.29 vs 2.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CRDO and ANAB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer